Fig. 1From: Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver diseaseLipid metabolic pathways and the regulation of berberine on the patients with IGR/Type 2 diabetes and nonalcoholic fatty liver diseaseBack to article page